Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: A pathologic analysis

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 3, 2004, Pages 722-730

  Vicini, Frank A ^a   Kestin, Larry L ^a   Goldstein, Neal S ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Breast conserving therapy; Partial breast irradiation

Indexed keywords

IRRADIATION; PATHOLOGY; RADIOTHERAPY; TUMORS;

BREAST CANCER; CLINICAL TARGET VOLUME (CTV); LUMPECTOMY; PATHOLOGIC ANALYSIS;

ONCOLOGY;

ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER STAGING; CARCINOMA IN SITU; CONTROLLED STUDY; EARLY CANCER; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PARTIAL MASTECTOMY; PATHOLOGIST; PRIORITY JOURNAL; RADIATION DOSE; REOPERATION;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; REOPERATION;

EID: 4744361569     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.04.012     Document Type: Article

References (16)

1. Vicini F.A., Kestin L., Chen P., et al. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst. 95:2003;1205-1210
2. Wallner P., Arthur D., Bartelink H., et al. Workshop on partial breast irradiation State of the art and the science, Bethesda, MD, December 8-10, 2002. J Natl Cancer Inst. 96:2004;175-184
3. Goldstein N.S., Kestin L., Vicini F. Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy. A clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol. 120:2003;500-527
4. Froud P.J., Mates D., Jackson J.S., et al. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys. 46:2000;363-372
5. Page D.L., Rogers L.W. Combined histologic and cytologic criteria for the diagnosis on mammary atypical ductal hyperplasia. Hum Pathol. 23:1992;1095-1097
6. King T.A., Bolton J.S., Kuske R.R., et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg. 180:2000;299-304
7. Vicini F.A., Baglan K.L., Kestin L.L., et al. Accelerated treatment of breast cancer. J Clin Oncol. 19:2001;1993-2001
8. Vicini F.A., Kestin L.L., Edmundson G.K., et al. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys. 45:1999;803-810
9. Kestin L.L., Jaffray D.A., Edmundson G.K., et al. Improving the dosimetric coverage of interstitial high-dose-rate breast implants. Int J Radiat Oncol Biol Phys. 46:2000;35-43
10. Holland R., Connolly J.L., Gelman R., et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol. 8:1990;113-118
11. Faverly D., Holland R., Burgers L. An original stereomicroscopic analysis of the mammary glandular tree. Virchows Arch A Pathol Anat Histopathol. 421:1992;115-119
12. Ohtake T., Abe R., Kimijima I., et al. Intraductal extension of primary invasive breast carcinoma treated by breast-conserving surgery. Computer graphic three-dimensional reconstruction of the mammary duct-lobular systems. Cancer. 76:1995;32-45
13. Imamura H., Haga S., Shimizu T., et al. Relationship between the morphological and biological characteristics of intraductal components accompanying invasive ductal breast carcinoma and patient age. Breast Cancer Res Treat. 62:2000;177-184
14. Olivotto I.A., Rose M.A., Osteen R.T., et al. Late cosmetic outcome after conservative surgery and radiotherapy analysis of causes of cosmetic failure. Int J Radiat Oncol Biol Phys. 17:1989;747-753
15. Bartelink H., Horiot J.C., Poortmans P.M., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med. 345:2001;1378-1387
16. Romestaing P., Lehingue Y., Carrie C., et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer results of a randomized clinical trial in Lyon, France. J Clin Oncol. 15:1997;963-968